Weekly Scoop #83

✨ €17M raised, $10M for hormone health and new funding for women’s care this week
Author:
Femi Adetoro
Published:
January 23, 2026

🧬 ErVimmune raises €17M Series A first closing to enter clinical development with lead cancer vaccine candidate

ErVimmune has raised€17 million to advance its lead therapeutic cancer vaccine into clinical development, targeting tumour antigens derived from human endogenous retroviruses with applications across multiple cancer types.


“This funding marks a critical milestone in bringing our off-the-shelf cancer vaccine to the clinic, our approach has the potential to transform treatment options for patients with difficult-to-treat cancers.”
— Prof. Stéphane Depil, Founder& Board Member, ErVimmune

🔗 https://www.pharmiweb.com/press-release/2026-01-21/ervimmune-raises-17-million-in-series-a-first-closing-to-enter-clinical-development-with-lead-cance

💊 Science&Humans closes over subscribed $10M Series A as hormone health enters mainstream care

Science&Humanshas closed an oversubscribed $10 million Series A combining equity and debt to expand access to clinically guided hormone and menopause care across Canada.

“Hormone health was not treated as a category in Canada when we started, this funding reflects a broader shift in how healthcare systems, employers, and patients are thinking about daily wellness, mental health, and long-term outcomes.” — Aftab Pashaw, Co-Founder & CEO, Science&Humans

🔗 https://ca.finance.yahoo.com/news/science-humans-closes-10m-oversubscribed-213300968.html

🌍 Novo Holdings invests in Surya Hospitals to expand women’s and children’s healthcare in India

Novo Holdings has acquired a 49 percent stake in Surya Hospitals, a women’s and children’s specialty hospital network in western India, supporting expansion of high quality maternal and paediatric care.

"Specialised healthcare delivery is a key focus for Novo Holdings in India, [...] We are pleased to partner with Surya as a long-term investor and support its ambition to broaden access to high-quality maternal and paediatric care." — Amit Kakar, Managing Partner & Head of Asia,  Novo Holdings

🔗 https://www.prnewswire.com/apac/news-releases/novo-holdings-invests-in-surya-hospitals-to-strengthen-access-to-high-quality-womens-and-childrens-healthcare-in-india-302664879.html

🏴 Scottish Government commits £2.4M to cut gynaecology waiting times under Women’s Health Plan Phase Two

The Scottish Government has announced more than £2.4 million in funding to improve gynaecology services and reduce waiting times as part of the second phase of its Women’s Health Plan.


"This year, we have already allocated over £10.5 million for gynaecology, and I am very pleased to announce today a further commitment of £2.4 million to tackle the longest waits – bringing additional funding to nearly £13 million." —
Jenni Minto, Women's Health Minister, Scottish Parliament

🔗 https://uk.news.yahoo.com/scottish-government-announces-extra-2-140246555.html

🎗️ Morgan Pressel’s Mammo Van initiative raises $1.3M to support breast cancer screening

LPGA golfer Morgan Pressel’s annual Morgan and Friends tournament raised $1.3million to support breast cancer detection and care through the Mammo Van programme, improving access to screening services.

🔗 https://golfweek-eu.usatoday.com/story/sports/golf/lpga/2026/01/15/morgan-pressel-raises-1-3-million-fight-against-breast-cancer-mammovan/88185239007/

🤖 Pinky Promise raises $1M pre-seed to scale India’s AI-led digital clinic for women

India’s Pinky Promise has raised $1 million in pre-seed funding led by Rebalance Angel Community to expand its chat-first digital clinic model and scale women’s health services nationwide.

🔗 https://www.digitalhealthnews.com/india-s-first-ai-led-digital-clinic-for-women-pinky-promise-raises-1m-pre-seed-funding